D. C. Angus and T. Van-der-poll, Severe sepsis and septic shock, N. Engl. J. Med, vol.369, pp.840-851, 2013.

R. S. Hotchkiss, G. Monneret, and D. Payen, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nat. Rev. Immunol, vol.13, pp.862-874, 2013.

R. J. Arts, M. S. Gresnigt, L. A. Joosten, and M. G. Netea, Cellular metabolism of myeloid cells in sepsis, J. Leukoc. Biol, vol.101, pp.151-164, 2017.

S. Cheng, Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis, Nat. Immunol, vol.17, pp.406-413, 2016.

D. C. Nascimento, IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population, Nat. Commun, vol.8, p.14919, 2017.

S. Cheng, mTOR-and HIF-1?-mediated aerobic glycolysis as metabolic basis for trained immunity, Science, vol.345, p.1250684, 2014.

R. Medzhitov, Origin and physiological roles of inflammation, Nature, vol.454, pp.428-435, 2008.

E. Latz, T. S. Xiao, and A. Stutz, Activation and regulation of the inflammasomes, Nat. Rev. Immunol, vol.13, pp.397-411, 2013.

H. Wang, H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey, HMGB1 as a late mediator of lethal systemic inflammation, Am. J. Respir. Crit. Care Med, vol.164, pp.1768-1773, 2001.

D. Novick, S. Kim, G. Kaplanski, and C. A. Dinarello, Interleukin-18, more than a Th1 cytokine, Semin. Immunol, vol.25, pp.439-448, 2013.

C. A. Dinarello, Interleukin-1beta, Crit. Care Med, vol.33, pp.460-462, 2005.

D. Virgilio, F. Ben, D. Sarti, A. C. Giuliani, A. L. Falzoni et al., The P2X7 receptor in infection and inflammation, Immunity, vol.47, pp.15-31, 2017.

K. Schroder and J. Tschopp, The inflammasomes, Cell, vol.140, pp.821-832, 2010.

A. Baroja-mazo, The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response, Nat. Immunol, vol.15, pp.738-748, 2014.

B. S. Franklin, The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation, Nat. Immunol, vol.15, pp.727-737, 2014.

K. F. Esquerdo, Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors, Clin. Exp. Immunol, vol.189, pp.232-240, 2017.

E. J. Giamarellos-bourboulis, Inhibition of caspase-1 activation in Gramnegative sepsis and experimental endotoxemia, Crit. Care, vol.15, p.27, 2011.

L. Jin, S. Batra, and S. Jeyaseelan, Deletion of Nlrp3 augments survival during polymicrobial sepsis by decreasing autophagy and enhancing phagocytosis, J. Immunol, vol.198, pp.1253-1262, 2017.

M. Xie, PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation, Nat. Commun, vol.7, p.13280, 2016.

P. T. Santana, The P2X7 receptor contributes to the development of the exacerbated inflammatory response associated with sepsis, J. Innate Immun, vol.7, pp.417-427, 2015.

B. Csóka, Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing, FASEB J, vol.29, pp.3626-3637, 2015.

A. Greve, P2X1, P2X4, and P2X7 receptor knock out mice expose differential outcome of sepsis induced by ?-haemolysin producing Escherichia coli, Front. Cell. Infect. Microbiol, vol.7, p.113, 2017.

S. Ruiz, Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture, Intensive Care Med. Exp, vol.4, p.22, 2016.

M. V. Eidt, Biochemical and inflammatory aspects in patients with severe sepsis and septic shock: the predictive role of IL-18 in mortality, Clin. Chim. Acta, vol.453, pp.100-106, 2016.

M. M. Gaidt, Human monocytes engage an alternative inflammasome pathway, Immunity, vol.44, pp.833-846, 2016.

M. Kalbitz, Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis, FASEB J, vol.30, pp.3997-4006, 2016.

K. T. Cheng, Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury, J. Clin. Invest, vol.127, pp.4124-4135, 2017.

T. Dolinay, Inflammasome-regulated cytokines are critical mediators of acute lung injury, Am. J. Respir. Crit. Care Med, vol.185, pp.1225-1234, 2012.

S. R. Grobmyer, Elevation of IL-18 in human sepsis, J. Clin. Immunol, vol.20, pp.212-215, 2000.

A. E. Jones, S. Trzeciak, and J. A. Kline, The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation, Crit. Care Med, vol.37, pp.1649-1654, 2009.

I. Belikova, Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis, Crit. Care Med, vol.35, pp.2702-2708, 2007.

A. M. Japiassú, Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5?-triphosphate synthase activity, Crit. Care Med, vol.39, pp.1056-1063, 2011.

A. B. Mackenzie, M. T. Young, E. Adinolfi, and A. Surprenant, Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors, J. Biol. Chem, vol.280, pp.33968-33976, 2005.

W. Danquah, Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation, Sci. Transl. Med, vol.8, pp.366-162, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01403925

R. Herrán-monge, Epidemiology and changes in mortality of sepsis after the implementation of surviving sepsis campaign guidelines, J. Intensive Care Med, p.088506661771188, 2017.

S. Harbarth, Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis, Am. J. Respir. Crit. Care Med, vol.164, pp.396-402, 2001.

I. Cinel and S. M. Opal, Molecular biology of inflammation and sepsis: a primer, Crit. Care Med, vol.37, pp.291-304, 2009.

S. Mera, Multiplex cytokine profiling in patients with sepsis, APMIS, vol.119, pp.155-163, 2010.

C. A. Gogos, E. Drosou, H. P. Bassaris, and A. Skoutelis, Pro-versus antiinflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options, J. Infect. Dis, vol.181, pp.176-180, 2000.

W. Ertel, Downregulation of proinflammatory cytokine release in whole blood from septic patients, Blood, vol.85, pp.1341-1347, 1995.

J. S. Boomer, Immunosuppression in patients who die of sepsis and multiple organ failure, JAMA, vol.306, pp.2594-2605, 2011.

W. D. Döcke, Monocyte deactivation in septic patients: restoration by IFN-gamma treatment, Nat. Med, vol.3, pp.678-681, 1997.

C. Munoz, Dysregulation of in vitro cytokine production by monocytes during sepsis, J. Clin. Invest, vol.88, pp.1747-1754, 1991.

I. N. Shalova, Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1?, Immunity, vol.42, pp.484-498, 2015.

M. Van-deuren, Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections, J. Infect. Dis, vol.177, pp.1401-1405, 1998.

F. Fattahi and P. A. Ward, Understanding Immunosuppression after sepsis, Immunity, vol.47, pp.3-5, 2017.

R. J. Fahy, Inflammasome mRNA expression in human monocytes during early septic shock, Am. J. Respir. Crit. Care Med, vol.177, pp.983-988, 2008.

W. Xiao, A genomic storm in critically injured humans, J. Exp. Med, vol.208, pp.2581-2590, 2011.

M. Albertsmeier, Monocyte-dependent suppression of T-cell function in postoperative patients and abdominal sepsis, Shock, vol.48, pp.651-656, 2017.

S. K. Biswas and E. Lopez-collazo, Endotoxin tolerance: new mechanisms, molecules and clinical significance, Trends Immunol, vol.30, pp.475-487, 2009.

J. Garaude, Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense, Nat. Immunol, vol.17, pp.1037-1045, 2016.

S. E. Corcoran and L. A. O'neill, HIF1? and metabolic reprogramming in inflammation, J. Clin. Invest, vol.126, pp.3699-3707, 2016.

E. L. Mills, Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages, Cell, vol.167, pp.457-470, 2016.

F. Amoroso, S. Falzoni, E. Adinolfi, D. Ferrari, and F. Di-virgilio, The P2X7 receptor is a key modulator of aerobic glycolysis, Cell Death Dis, vol.3, p.370, 2012.

F. Amoroso, The P2X7 receptor is a key modulator of the PI3K/GSK3?/ VEGF signaling network: evidence in experimental neuroblastoma, Oncogene, vol.34, pp.5240-5251, 2015.

Y. Hirayama, Astrocyte-mediated ischemic tolerance, J. Neurosci, vol.35, pp.3794-3805, 2015.

J. Yu, Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy, Proc. Natl Acad. Sci, vol.111, pp.15514-15519, 2014.

P. Pelegrin and A. Surprenant, Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates, EMBO J, vol.28, pp.2114-2127, 2009.

I. Martins, Chemotherapy induces ATP release from tumor cells, Cell Cycle, vol.8, pp.3723-3728, 2009.

M. M. Levy, SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, vol.31, pp.1250-1256, 2001.

C. De-torre-minguela, M. Barberà-cremades, A. I. Gómez, F. Martín-sánchez, and P. Pelegrín, Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process, Sci. Rep, vol.6, p.22586, 2016.

G. Buell, Blockade of human P2X7 receptor function with a monoclonal antibody, Blood, vol.92, pp.3521-3528, 1998.

A. Cossarizza, Guidelines for the use of flow cytometry and cell sorting in immunological studies, Eur. J. Immunol, vol.47, pp.1584-1797, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01619848

. Competitividad-fondo, Europeo de Desarrollo Regional (SAF2017-88276-R to P.Pe.), Fundación Séneca (20859/PI/18 to P.Pe.) and European Research Council